Latest Insider Transactions at Lava Therapeutics Nv (LVTX)
This section provides a real-time view of insider transactions for Lava Therapeutics Nv (LVTX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of LAVA Therapeutics NV to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of LAVA Therapeutics NV's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 13
2025
|
Stephen A Hurly Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
5,000
-100.0%
|
-
|
|
Nov 13
2025
|
Kapil Dhingra |
SELL
Sale (or disposition) back to the issuer
|
Direct |
30,000
-100.0%
|
-
|
|
Nov 13
2025
|
Karen J Wilson |
SELL
Sale (or disposition) back to the issuer
|
Direct |
10,000
-100.0%
|
-
|
|
Nov 13
2025
|
Fred M Powell Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
65,000
-100.0%
|
-
|
|
Oct 17
2025
|
Gilde Healthcare Iv U.A. Cooperatieve |
SELL
Open market or private sale
|
Direct |
1,181,131
-28.61%
|
$1,181,131
$1.47 P/Share
|
|
Oct 16
2025
|
Gilde Healthcare Iv U.A. Cooperatieve |
SELL
Open market or private sale
|
Direct |
690,239
-14.32%
|
$690,239
$1.49 P/Share
|
|
Oct 14
2025
|
Gilde Healthcare Iv U.A. Cooperatieve |
SELL
Open market or private sale
|
Direct |
227,341
-4.33%
|
$227,341
$1.51 P/Share
|
|
Oct 13
2025
|
Gilde Healthcare Iv U.A. Cooperatieve |
SELL
Open market or private sale
|
Direct |
47,686
-0.9%
|
$47,686
$1.54 P/Share
|
|
Oct 10
2025
|
Gilde Healthcare Iv U.A. Cooperatieve |
SELL
Open market or private sale
|
Direct |
49,869
-0.93%
|
$49,869
$1.55 P/Share
|
|
Oct 09
2025
|
Gilde Healthcare Iv U.A. Cooperatieve |
SELL
Open market or private sale
|
Direct |
48,169
-0.89%
|
$48,169
$1.56 P/Share
|
|
Oct 08
2025
|
Gilde Healthcare Iv U.A. Cooperatieve |
SELL
Open market or private sale
|
Direct |
28,954
-0.53%
|
$28,954
$1.57 P/Share
|
|
Sep 19
2025
|
Versant Venture Capital Vi, L.P. |
SELL
Open market or private sale
|
Indirect |
532,870
-100.0%
|
$532,870
$1.4 P/Share
|
|
Sep 19
2025
|
Versant Venture Capital Vi, L.P. |
SELL
Open market or private sale
|
Direct |
2,370,533
-100.0%
|
$2,370,533
$1.4 P/Share
|
|
Sep 18
2025
|
Versant Venture Capital Vi, L.P. |
SELL
Open market or private sale
|
Indirect |
228,791
-30.04%
|
$228,791
$1.44 P/Share
|
|
Sep 18
2025
|
Versant Venture Capital Vi, L.P. |
SELL
Open market or private sale
|
Direct |
366,111
-13.38%
|
$366,111
$1.44 P/Share
|
|
Sep 17
2025
|
Versant Venture Capital Vi, L.P. |
SELL
Open market or private sale
|
Indirect |
226,726
-22.94%
|
$226,726
$1.49 P/Share
|
|
Sep 17
2025
|
Versant Venture Capital Vi, L.P. |
SELL
Open market or private sale
|
Direct |
362,806
-11.71%
|
$362,806
$1.49 P/Share
|
|
Sep 16
2025
|
Versant Venture Capital Vi, L.P. |
SELL
Open market or private sale
|
Indirect |
192,293
-16.29%
|
$192,293
$1.53 P/Share
|
|
Sep 16
2025
|
Versant Venture Capital Vi, L.P. |
SELL
Open market or private sale
|
Direct |
307,707
-9.03%
|
$307,707
$1.53 P/Share
|
|
Oct 20
2015
|
Gilde Healthcare Iv U.A. Cooperatieve |
SELL
Open market or private sale
|
Direct |
1,000,000
-33.92%
|
$1,000,000
$1.46 P/Share
|
|
Oct 15
2015
|
Gilde Healthcare Iv U.A. Cooperatieve |
SELL
Open market or private sale
|
Direct |
200,000
-3.98%
|
$200,000
$1.51 P/Share
|